E. Gerlo

702 total citations
27 papers, 527 citations indexed

About

E. Gerlo is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, E. Gerlo has authored 27 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Surgery and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in E. Gerlo's work include Mitochondrial Function and Pathology (5 papers), Metabolism and Genetic Disorders (4 papers) and Adrenal and Paraganglionic Tumors (4 papers). E. Gerlo is often cited by papers focused on Mitochondrial Function and Pathology (5 papers), Metabolism and Genetic Disorders (4 papers) and Adrenal and Paraganglionic Tumors (4 papers). E. Gerlo collaborates with scholars based in Belgium, Netherlands and United States. E. Gerlo's co-authors include Willy Lissens, Joél Smet, Sara Seneca, Linda De Meırleır, Rudy Van Coster, Inge De Clercq, François Eyskens, Frans Gorus, Chantal Mathieu and Bart Devreese and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Diabetologia.

In The Last Decade

E. Gerlo

26 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Gerlo Belgium 11 280 124 112 105 59 27 527
Sun Ha Lee South Korea 11 155 0.6× 54 0.4× 62 0.6× 70 0.7× 25 0.4× 16 406
Ferhan Siddiqi Canada 11 280 1.0× 37 0.3× 63 0.6× 91 0.9× 65 1.1× 22 560
José María Manzanares Spain 9 254 0.9× 38 0.3× 53 0.5× 73 0.7× 25 0.4× 15 428
Peter I. Karl United States 15 161 0.6× 45 0.4× 58 0.5× 51 0.5× 20 0.3× 37 661
Chakradhar Velagapudi United States 8 254 0.9× 42 0.3× 51 0.5× 31 0.3× 47 0.8× 11 463
F Poggi France 14 403 1.4× 478 3.9× 56 0.5× 55 0.5× 16 0.3× 22 635
Alan W. Hodson United Kingdom 10 173 0.6× 57 0.5× 101 0.9× 244 2.3× 11 0.2× 32 550
Mary Anne Preece United Kingdom 11 162 0.6× 166 1.3× 56 0.5× 41 0.4× 18 0.3× 20 377
John F. Nicholson United States 13 267 1.0× 301 2.4× 91 0.8× 73 0.7× 13 0.2× 27 769
Ference J. Loupatty Netherlands 9 214 0.8× 147 1.2× 44 0.4× 32 0.3× 11 0.2× 9 395

Countries citing papers authored by E. Gerlo

Since Specialization
Citations

This map shows the geographic impact of E. Gerlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Gerlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Gerlo more than expected).

Fields of papers citing papers by E. Gerlo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Gerlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Gerlo. The network helps show where E. Gerlo may publish in the future.

Co-authorship network of co-authors of E. Gerlo

This figure shows the co-authorship network connecting the top 25 collaborators of E. Gerlo. A scholar is included among the top collaborators of E. Gerlo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Gerlo. E. Gerlo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michielsen, D., et al.. (2006). INDOXYL SULPHATE AND THE PURPLE URINE BAG SYNDROME: A CASE REPORT. Acta Clinica Belgica. 61(1). 38–41. 5 indexed citations
2.
Gorus, Frans, Chantal Mathieu, & E. Gerlo. (2005). How should HbA1c measurements be reported?. Diabetologia. 49(1). 7–10. 33 indexed citations
3.
Coster, Rudy N. Van, E. Gerlo, Thierry Giardina, et al.. (2005). Aminoacylase I deficiency: A novel inborn error of metabolism. Biochemical and Biophysical Research Communications. 338(3). 1322–1326. 44 indexed citations
4.
Grève, Jacques De, Christel Fontaine, Ann Meulemans, et al.. (2005). Prospective study of fatigue and metabolic parameters in patients with early breast cancer (EBC) receiving concomitant radiotherapy and anthracycline-based adjuvant chemotherapy. Journal of Clinical Oncology. 23(16_suppl). 852–852. 1 indexed citations
5.
Meırleır, Linda De, Sara Seneca, Willy Lissens, et al.. (2004). Respiratory chain complex V deficiency due to a mutation in the assembly gene ATP12. Journal of Medical Genetics. 41(2). 120–124. 143 indexed citations
6.
Coster, Rudy Van, Sara Seneca, Joél Smet, et al.. (2003). Homozygous Gly555Glu mutation in the nuclear‐encoded 70 kDa flavoprotein gene causes instability of the respiratory chain complex II. American Journal of Medical Genetics Part A. 120A(1). 13–18. 60 indexed citations
7.
Blomme, Bram, E. Gerlo, Bruno Hauser, & Yvan Vandenplas. (2003). Disaccharidase activities in Belgian children: reference intervals and comparison with non‐Belgian Caucasian children. Acta Paediatrica. 92(7). 806–810. 10 indexed citations
8.
Lheureux, Philippe, et al.. (2001). Cobas Mira  S Endpoint Enzymatic Assay for Plasma Formate. Journal of Analytical Toxicology. 25(2). 77–80. 7 indexed citations
9.
Gibson, K. Michael, Rebecca S. Wappner, Elardus Erasmus, et al.. (1998). Variable clinical presentation in three patients with 3‐methylglutaconyl‐coenzyme A hydratase deficiency. Journal of Inherited Metabolic Disease. 21(6). 631–638. 15 indexed citations
10.
Hauser, Bruno, Uwe Blecker, Kathelijn Keymolen, et al.. (1997). Plasma Amino Acid Concentrations in Term‐Born Infants Fed a Whey Predominant or a Whey Hydrolysate Formula. Journal of Parenteral and Enteral Nutrition. 21(1). 27–30. 9 indexed citations
11.
Noppen, Marc, et al.. (1997). Plasma catecholamine concentrations in essential hyperhidrosis and effects of thoracoscopic D2–D3 sympathicolysis. European Journal of Clinical Investigation. 27(3). 202–205. 20 indexed citations
12.
Denis, R, J. Wayenberg, Frans Gorus, et al.. (1996). Hyperphosphatasemia In early Diagnosed Infantile Gm1 Gangliosidosis Presenting As Transient Hydrops Fetalis.. Acta Clinica Belgica. 51(5). 320–327. 7 indexed citations
13.
Gerlo, E., et al.. (1995). Decreased Urinary Dopamine Excretion and Disturbed Dopamine/Sodium Relationship in Type 1 Diabetes Mellitus. Diabetic Medicine. 12(3). 229–234. 8 indexed citations
14.
Gerlo, E., et al.. (1994). Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases. Clinical Chemistry. 40(2). 250–256. 89 indexed citations
15.
Wayenberg, J., Danièle Vermeylen, E. Gerlo, & Anne Pardou. (1992). Increased intracranial pressure in a neonate with citrullinaemia. European Journal of Pediatrics. 151(2). 132–133. 5 indexed citations
16.
Spapen, Herbert, E. Gerlo, Eric Achten, et al.. (1989). Pre- and peroperative diagnosis of metastatic pheochromocytoma in multiple endocrine neoplasia type 2a. Journal of Endocrinological Investigation. 12(10). 729–731. 6 indexed citations
17.
Smitz, Johan, et al.. (1989). The respective effects of serum thyroxine and triiodothyronine on serum thyrotropin and lipid parameters in endemic juvenile hypothyroidism. European Journal of Endocrinology. 121(5). 691–697. 2 indexed citations
18.
Gerlo, E., Frans Gorus, & Kenny De Meirleir. (1987). Automated micro-method for determining L-(+)-lactate in arterialized whole blood.. Clinical Chemistry. 33(1). 188–189. 3 indexed citations
19.
Gerlo, E., et al.. (1975). Proceedings: Evidence for specific NADH- and NADPH-FMN reductases in bacterial bioluminescence.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 83(2). 354–6. 1 indexed citations
20.
Gerlo, E., et al.. (1971). Bioluminescence assay of reduced pyridine and flavine nucleotides with bacterial luciferase.. PubMed. 79(1). 200–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sun Ha Lee Breakdown of academic impact, for papers by Ferhan Siddiqi Breakdown of academic impact, for papers by José María Manzanares Breakdown of academic impact, for papers by Peter I. Karl Breakdown of academic impact, for papers by Chakradhar Velagapudi Breakdown of academic impact, for papers by F Poggi Breakdown of academic impact, for papers by Alan W. Hodson Breakdown of academic impact, for papers by Mary Anne Preece Breakdown of academic impact, for papers by John F. Nicholson Breakdown of academic impact, for papers by Ference J. Loupatty
Rankless by CCL
2026